App catalogs are flush with titles that allow users to play doctor, but according to the FDA, most of them are harmless and don't warrant regulatory oversight. Instead, the agency has announced that it'll take a more reactive, risk-based approach and will only require approval for mobile apps that "present a greater risk to patients if they do not work as intended." Specifically, the FDA will scrutinize a
